Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan (Tables)

v3.23.2
Equity Incentive Plan (Tables)
 6 Months Ended
Jun. 30, 2023
Equity Incentive Plan [Abstract]  
Schedule of Share-Based Compensation Expense The Company recorded share-based compensation expense in the following expense categories in the condensed consolidated statements of operations and comprehensive loss for the six months ended June 30, 2023 and 2022
Stock Options & SARs   Three Months Ended
June 30,		     Six Months Ended
June 30,		  
(in thousands)   2023     2022     2023     2022  
General and administrative   $ 277     $ 344     $ 511     $ 654  
Sales and marketing     64       42       123       70  
Research and development     93       81       184       146  
Cost of revenues     27       24       53       45  
    $ 461     $ 491     $ 871     $ 915  
RSUs   Three Months Ended
June 30,		     Six Months Ended
June 30,		  
(in thousands)   2023     2022     2023     2022  
General and administrative   $ 104     $
—
     $ 227     $
—
  
    $ 104     $
—
     $ 227     $
—
  
Schedule of Weighted Average Assumptions For the six months ended June 30, 2023 and 2022, the fair value of options granted was estimated using a Black-Scholes option pricing model with the following weighted average assumptions
    Six Months Ended
June 30,		  
    2023     2022  
Expected term (in years)     5.9       5.9  
Expected volatility     57.1 %     54.4 %
Risk-free rate     3.9 %     1.9 %
Dividend rate    
—
      
—
  
Schedule of Stock Option Activity The following table summarizes stock option activity under the 2020 Plan for the six months ended June 30, 2023
Stock Option & SARs   Number of
Shares
under
Equity
Plan		     Weighted-
Average
Exercise
Price per
Option		     Weighted-
Average
Remaining
Contractual
Life
(in years)		  
Outstanding at December 31, 2022     8,234,823     $ 1.82       7.7  
Granted     1,681,946     $ 2.00          
Exercised     (216,416 )   $ 1.22          
Forfeited and expired     (137,732 )   $ 2.03          
Outstanding at June 30, 2023     9,562,621     $ 1.91       7.7  
Exercisable at June 30, 2023     5,572,830     $ 1.55       6.9  
Vested and expected to vest at June 30, 2023     9,562,621     $ 1.91       7.7  
RSUs   Number of
Shares under
Equity Plan		     Weighted
Average
Grant Date
Fair Value		  
Outstanding at December 31, 2022     263,155     $ 1.90  
Granted    
—
     $
—
  
Exercised    
—
     $
—
  
Forfeited and expired    
—
     $
—
  
Outstanding at June 30, 2023     263,155     $ 1.90